Forinash Recognized for Vital Contributions to Maternal-Fetal Medicine
Published on 28 November 2017
Alicia B. Forinash, Pharm.D., FCCP, BCPS, BCACP, served as a co-author on the recently published Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 11th Edition
Forinash played a significant role in writing and editing the updated edition, which lists more than 1,200 commonly prescribed medications taken during pregnancy and lactation. The reference guide also includes detailed monographs that provide information regarding known or possible effects on the mother, embryo, fetus and nursing infant.
Forinash, a clinical pharmacist specialist in obstetrics, is considered an expert on the effects of medications on the embryo-fetus and nursing infant.
“Women’s health has always been my interest area,” shared Forinash. “I find maternal-fetal medicine to be a great fit because each individual patient situation is unique. I enjoy the challenge of each unique situation to research different diseases and medications to best treat and educate my patients.”
Forinash’s career accomplishments were recently recognized by the American College of Clinical Pharmacy (ACCP) Women’s Health Practice and Research Network (PRN), which presented her with its Vital Contributions to Women’s Health Award. The award honors an outstanding member of the ACCP Women’s Health PRN who has significantly advanced women’s health through scholarly contributions, distinguished teaching, clinical practice and advocacy.
With a career that has been guided by her commitment to women’s health, Forinash finds her role in pharmacy to be rewarding and well-suited to her interests and expertise. To students looking ahead to careers in pharmacy, she offers advice on finding the right path.
“When deciding what area of pharmacy is best for you, find out through experience where your heart really lies,” Forinash said. “My mantra is always to treat every patient like they are your family member. You will then be the best advocate for their therapy, medication safety and patient education.”